Luqa Acquires China Rights to Next-Gen Dermal Filler
January 11, 2016 at 06:07 AM EST
Luqa Pharmaceuticals, a China dermatological in-licensing company, has acquired greater China rights to a next-generation dermal filler. Luqa did not identify the product or the maker, but did say the filler would be available in a range of formats. According to Luqa, the new dermal product is a first-in-class dermal filler that works by first filling skin wrinkles, and then stimulating the production of collagen. Luqa will be responsible for development, sales, marketing and distribution in China, Hong Kong and Macau with a launch expected during the first half of 2016. More details.... Share this with colleagues: // //